Stockscreener 앱 받기
939.47
1.65%
-15.72
시장 영업 전:
935.81
-3.66
-0.39%
Lilly Eli Co 주식(LLY)의 최신 뉴스
Dementia Market Insight, Epidemiology, and Forecasts, 2022-2025 & 2026-2034 - GlobeNewswire Inc.
Mounjaro maker Lilly eyes India rollout for oral obesity drug orforglipron - Moneycontrol.com
Eli Lilly's Q1 GLP-1 Sales to Exceed Market Expectations, RBC Says - Moomoo
Eli Lilly Balances India GLP-1 Generics Shock With Foundayo U.S. Push - simplywall.st
Yousif Capital Management Trims Stake in Eli Lilly - National Today
Eli Lilly's Dual-Pronged Strategy: A Pill Launch and a $6.3 Billion Bet - AD HOC NEWS
Eli Lilly's Weight Loss Portfolio: Zepbound and Retatrutide StrategyNews and Statistics - IndexBox
Jackson Square Capital LLC Boosts Eli Lilly and Company Holdings - National Today
🚨 In case you missed it, we broke down one of the most significant shifts happening in biotech right now. Eli Lilly and Company is using LillyPod and AI to aggressively accelerate drug discovery timelines and reshape how research and development works at s - LinkedIn
BIP Wealth LLC Boosts Eli Lilly Stake by 161% - National Today
Assessing Eli Lilly (LLY) Valuation After A 13% Year To Date Share Price Pullback - simplywall.st
FDA Approves Eli Lilly's New Weight-Loss Pill: Foundayo Explained - National Today
Eli Lilly Isn't Replacing Zepbound -- It's Building an Obesity Empire - The Motley Fool
Steadtrust LLC Acquires 1,197 Shares in Eli Lilly - National Today
Steadtrust LLC Acquires $1.3M Stake in Eli Lilly - National Today
Eli Lilly Price Target Raised to $880 by Rothschild & Co Redburn - National Today
Foundayo Explained: Lilly’s New Weight Loss Pill And The Amazon Effect (NYSE:LLY) - Seeking Alpha
Eli Lilly and Co (WAR:LILY) Beta : N/A (As of Apr. 11, 2026) - GuruFocus
Eli Lilly's Weight-Loss Pill Debuts Amid Shifting Market Dynamics - AD HOC NEWS
RBC Capital reiterates Eli Lilly stock rating on GLP-1 strength - Investing.com Canada
Stock Quote & Chart - Eli Lilly
Western Financial Corp CA Boosts Stake in Eli Lilly - National Today
Eli Lilly vs. Novo Nordisk: The Obesity Drug Race Has a New Leader - 24/7 Wall St.
Eli Lilly's Foundayo Forges New Path with Amazon as Political Headwinds Bite - AD HOC NEWS
Eli Lilly (LLY) Analyst Ratings Data: April 2026 Updates | LLY S - GuruFocus
Amazon Pharmacy adds same-day delivery for Eli Lilly's Foundayo weight-loss pill - qz.com
With oral obesity race underway, all eyes are on Lilly’s Foundayo launch - BioSpace
Eli Lilly (LLY) Expands Patient Access to Foundayo for Weight Ma - GuruFocus
LifeMD adds Eli Lilly’s oral weight loss drug to platform By Investing.com - Investing.com India
Amazon Pharmacy to offer Eli Lilly’s Foundayo via same-day delivery - Yahoo Finance
Eli Lilly loses weight loss drug market share as generics flood India - Yahoo Finance
Morgan Stanley Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Raises Target Price to $1,327 - 富途牛牛
LifeMD adds Eli Lilly’s oral weight loss drug to platform - Investing.com
LifeMD® Now Offering Eli Lilly and Company’s Foundayo™ (orforglipron), a New GLP-1 Pill for Weight Management - The Manila Times
Who Benefits From Amazon Pharmacy Stocking Eli Lilly’s New Weight Loss Pill - 24/7 Wall St.
RBC Capital Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Maintains Target Price $1,250 - 富途牛牛
Lilly to acquire Centessa in deal worth up to $7.8bn - PMLiVE
Top 12 Pharma Companies: Eli Lilly Shoots To The Top, Merck Tumbles - Citeline News & Insights
Eli Lilly Expands Foundayo Obesity Launch As Valuation Signals Upside Potential - simplywall.st
Eli Lilly's proposal to acquire Orna Therapeutics sparks Australian review - MLex
LLY Stock Price, Quote & Chart | ELI LILLY & CO (NYSE:LLY) - ChartMill
Rep. Gilbert Ray Cisneros, Jr. Sells Eli Lilly Shares - National Today
Amazon to sell Eli Lilly's new weight-loss pill via kiosks, home delivery - IndyStar
UBS offers $3.094M Autocallable Notes linked to Lilly | AMUB Prospectus Summary - Stock Titan
Amazon Offers Same-Day Delivery of Eli Lilly’s (LLY) Weight-Loss Pill - TipRanks
Amazon Pharmacy to Offer Eli Lilly and Company’s New GLP-1 Pill Foundayo via Same-Day Delivery - Business Wire
Eli Lilly Stock in Focus -- New Pill Launch Challenges Novo Nordisk - GuruFocus
Lilly weight-loss pill Foundayo now available in United States - Inside INdiana Business
Amazon (AMZN.US) Pharmacy introduces Eli Lilly and Co's (LLY.US) weight-loss oral medication, with same-day delivery available in over 3,000 cities. - 富途牛牛
Eli Lilly Launches Foundayo Weight-Loss Pill. What It Means for the Stock. - Barron's
Amazon to stock Lilly's new weight-loss pill at US kiosks, offer same-day delivery - Reuters
Lobbying Update: $30,000 of TIBER CREEK HEALTH STRATEGIES INC. ON BEHALF OF ELI LILLY AND COMPANY lobbying was just disclosed - Quiver Quantitative
Amazon expands access to weight-loss pill with kiosks, same-day delivery - WTHR
GoodRx Expands Access to Eli Lilly's New Diabetes Medications - National Today
Amazon Pharmacy offers Eli Lilly’s GLP-1 pill Foundayo via Same-Day Delivery - Drug Store News
Eli Lilly's New Weight-Loss Pill Foundayo Hits U.S. Pharmacies - National Today
Eli Lilly Just Launched Its $149 Obesity Pill - Benzinga
Eli Lilly launches oral GLP-1 drug across US through Lilly Direct, telehealth providers - Fierce Healthcare
GoodRx and Eli Lilly Partner to Expand Access to Foundayo and Zepbound KwikPen - Pharmaceutical Commerce
Lilly launches GLP-1 pill, kicking off showdown with Novo Nordisk - BioPharma Dive
1.18%
자본화:
|
볼륨(24시간):